2023-04-25 16:54:28 ET
- ReShape Lifesciences press release ( NASDAQ: RSLS ): FY Revenue of $11.24M (-17.9% Y/Y) misses by $2.24M .
- Net loss of $46.21M
For further details see:
ReShape Lifesciences reports FY results2023-04-25 16:54:28 ET
For further details see:
ReShape Lifesciences reports FY resultsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
ReShape Lifesciences Inc. Company Name:
RSLS Stock Symbol:
Market:
ReShape Lifesciences Inc. Website:
2024-07-10 06:20:00 ET 3 Key Tips to Investing in Biotech Penny Stocks in 2024 Investing in biotech penny stocks offers an exciting opportunity to capitalize on the rapid advancements in medical and healthcare technologies. These small-cap stocks often belong to companies that are d...
CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, announced today that it has signed a merger agreement with ReShape Lifesciences (Na...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) fell 9.3% to $0.2448 on volume of 58,139,351 shares NVIDIA Corporation (NVDA) rose 2.9% to $131.9 on volume of 38,975,630 shares Soligenix Inc. (SNGX) rose 189.2% to $5.784 on volume of 36,915,609...